COMMISSION DELEGATED REGULATION (EU) 2022/1644 of 7 July 2022 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof ANNEX I ANNEX II Criteria for the selection of specific combination of substance groups and commodity groups for national risk-based control plan for production in the Member States (as referred to in Article 2(2)) ANNEX III Criteria for sampling strategy for national risk-based control plan for production in the Member States (as referred to in Article 2(2)) ANNEX IV Criteria for the selection of specific combination of substance groups and commodity groups for national randomised surveillance plan for production in the Member States (as referred to in Article 2(3)) ANNEX V Criteria for sampling strategy for national randomised surveillance plan for production in the Member States (as referred to in Article 2(3) ANNEX VI Criteria for the selection of specific combination of substance groups and commodity groups for national risk-based control plan for third country imports (as referred to in Article 2(4)) ANNEX VII Criteria for sampling strategy for national risk-based control plan for third country imports (as referred to in Article 2(4))

COMMISSION DELEGATED REGULATION (EU) 2022/1644 of 7 July 2022 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof ANNEX I ANNEX II Criteria for the selection of specific combination of substance groups and commodity groups for national risk-based control plan for production in the Member States (as referred to in Article 2(2)) ANNEX III Criteria for sampling strategy for national risk-based control plan for production in the Member States (as referred to in Article 2(2)) ANNEX IV Criteria for the selection of specific combination of substance groups and commodity groups for national randomised surveillance plan for production in the Member States (as referred to in Article 2(3)) ANNEX V Criteria for sampling strategy for national randomised surveillance plan for production in the Member States (as referred to in Article 2(3) ANNEX VI Criteria for the selection of specific combination of substance groups and commodity groups for national risk-based control plan for third country imports (as referred to in Article 2(4)) ANNEX VII Criteria for sampling strategy for national risk-based control plan for third country imports (as referred to in Article 2(4))eu-regulation-2022-x-x-1644